J P Lévy

4.1k total citations
121 papers, 3.3k citations indexed

About

J P Lévy is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, J P Lévy has authored 121 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Immunology, 28 papers in Epidemiology and 27 papers in Genetics. Recurrent topics in J P Lévy's work include Immune Cell Function and Interaction (46 papers), Immunotherapy and Immune Responses (34 papers) and T-cell and B-cell Immunology (32 papers). J P Lévy is often cited by papers focused on Immune Cell Function and Interaction (46 papers), Immunotherapy and Immune Responses (34 papers) and T-cell and B-cell Immunology (32 papers). J P Lévy collaborates with scholars based in France, Switzerland and Tunisia. J P Lévy's co-authors include E Gomard, J. C. Leclerc, Frédéric Martinon, Jean‐Gérard Guillet, I. Bourgault, M Boiron, M. T. Thomas, Jeannine Choppin, Gerlinde Lenzen and Pierre Meulien and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

J P Lévy

116 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J P Lévy France 33 2.1k 895 881 650 617 121 3.3k
E Gomard France 31 1.9k 0.9× 726 0.8× 986 1.1× 544 0.8× 361 0.6× 69 2.8k
Sisir K. Chattopadhyay United States 34 1.5k 0.7× 1.4k 1.6× 1.2k 1.4× 727 1.1× 1.4k 2.2× 86 4.2k
M Lieberman United States 20 1.3k 0.6× 573 0.6× 574 0.7× 314 0.5× 629 1.0× 42 2.5k
D Dina United States 28 816 0.4× 720 0.8× 1.3k 1.5× 686 1.1× 421 0.7× 44 2.9k
Kelledy Manson United States 31 2.1k 1.0× 925 1.0× 1.9k 2.2× 1.1k 1.7× 397 0.6× 47 3.7k
Chantal Rabourdin‐Combe France 39 2.7k 1.3× 1.4k 1.6× 367 0.4× 1.8k 2.8× 589 1.0× 94 5.0k
Yves Rivière France 39 2.5k 1.2× 1.1k 1.2× 2.9k 3.2× 1.2k 1.9× 431 0.7× 124 4.9k
Franziska Lechner Switzerland 20 2.5k 1.2× 388 0.4× 571 0.6× 1.4k 2.1× 212 0.3× 27 3.9k
H. T. M. Cuypers Netherlands 31 704 0.3× 1.1k 1.2× 727 0.8× 1.1k 1.7× 279 0.5× 53 3.4k
Ghalib Alkhatib United States 24 2.5k 1.2× 882 1.0× 2.8k 3.2× 886 1.4× 420 0.7× 38 4.4k

Countries citing papers authored by J P Lévy

Since Specialization
Citations

This map shows the geographic impact of J P Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J P Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J P Lévy more than expected).

Fields of papers citing papers by J P Lévy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J P Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J P Lévy. The network helps show where J P Lévy may publish in the future.

Co-authorship network of co-authors of J P Lévy

This figure shows the co-authorship network connecting the top 25 collaborators of J P Lévy. A scholar is included among the top collaborators of J P Lévy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J P Lévy. J P Lévy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lévy, J P. (2015). Questions about CD8+ Anti-HIV Lymphocytes in the Control of HIV Infection. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 48. 13–20.
2.
Kouach, Mostafa, Jean‐Michel Wieruszeski, André Tartar, et al.. (1999). Characterization of a multi-lipopeptides mixture used as an HIV-1 vaccine candidate. Vaccine. 18(3-4). 259–267. 37 indexed citations
3.
4.
Bourgault, I., A Venet, & J P Lévy. (1992). Three epitopic peptides of the simian immunodeficiency virus Nef protein recognized by macaque cytolytic T lymphocytes. Journal of Virology. 66(2). 750–756. 21 indexed citations
5.
Choppin, Jeannine, Frédéric Martinon, Francine Connan, et al.. (1991). HLA-binding regions of HIV-1 proteins. II. A systematic study of viral proteins. The Journal of Immunology. 147(2). 575–583. 13 indexed citations
6.
Choppin, Jeannine, Frédéric Martinon, Francine Connan, E Gomard, & J P Lévy. (1991). HLA-binding regions of HIV-1 proteins. I. Detection of seven HLA binding regions in the HIV-1 Nef protein. The Journal of Immunology. 147(2). 569–574. 13 indexed citations
7.
Martinon, Frédéric, E Gomard, C Hannoun, & J P Lévy. (1990). In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides. European Journal of Immunology. 20(10). 2171–2176. 19 indexed citations
8.
Bouillot, M, Jeannine Choppin, Fabrice Cornille, et al.. (1989). Physical association between MHC class I molecules and immunogenic peptides. Nature. 339(6224). 473–475. 85 indexed citations
9.
Lévy, J P. (1987). Centres villes en mutation. Éditions du Centre National de la Recherche Scientifique eBooks. 11 indexed citations
10.
Juy, Dominique, et al.. (1987). Polyclonal B-cell activation by influenza A/Texas virus-specific human T-cell clones. Annales de l Institut Pasteur Immunologie. 138(3). 371–382. 2 indexed citations
11.
Bagot, M., Michèle Heslan, Jean‐Claude Roujeau, Pierre Lebon, & J P Lévy. (1985). Human epidermal cells are more potent than peripheral blood mononuclear cells for the detection of weak allogeneic or virus-specific primary responses in vitro. Cellular Immunology. 94(1). 215–224. 16 indexed citations
12.
Simmler, Marie‐Christine, Philip Avner, & J P Lévy. (1982). Minor histocompatibility antigen expression on F9 embryonal carcinoma cells revealed by T-cell mediated responses. Immunogenetics. 16(4). 349–354. 11 indexed citations
13.
Boyer, Brigitte, S Gisselbrecht, Patrice Debré, Steven E. McKenzie, & J P Lévy. (1980). Genetic control of sensitivity to Moloney leukemia virus in mice. IV. Phenotypic heterogeneity of the leukemic mice.. The Journal of Immunology. 125(4). 1415–1420. 26 indexed citations
14.
Mathiot, Claire, et al.. (1978). [Multifocal chloroma (granulocytic sarcoma), without marrow involvement. One case (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7(28). 2461–3. 2 indexed citations
15.
Gisselbrecht, Sylvie, Christine Blaineau, & J P Lévy. (1978). Specific Inhibition of XC Syncytia Formation by Anti-MuLV gp69/71 Antibodies. Intervirology. 10(6). 338–344.
16.
Lévy, J P, et al.. (1977). Comparison Between a Prescribed and a Permissive Process in Computer Assisted Training in Decision Making.. IFIP Congress. 343–346. 1 indexed citations
17.
Gomard, E, et al.. (1977). Specific triggering by concanavalin A of a secondary T killer cell-mediated anti-tumor immune response. Cellular Immunology. 34(2). 299–309. 10 indexed citations
18.
Levy, Daniel, Aurora Parodi, J P Lévy, et al.. (1977). Bovine leukemia virus specific antibodies among french cattle. II. Radioimmunoassay with the major structural protein (BLV P24). International Journal of Cancer. 20(4). 543–550. 21 indexed citations
19.
Leclerc, J. C., E Gomard, Fernando Plata, & J P Lévy. (1973). Cell‐mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor‐cell cytolysis. International Journal of Cancer. 11(2). 426–432. 89 indexed citations
20.
Thomas, M. T., M Boiron, J Tanzer, J P Lévy, & Jean Bernard. (1964). In vitro Transformation of Mice Cells by Bovine Papilloma Virus. Nature. 202(4933). 709–710. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Gomard Breakdown of academic impact, for papers by Sisir K. Chattopadhyay Breakdown of academic impact, for papers by M Lieberman Breakdown of academic impact, for papers by D Dina Breakdown of academic impact, for papers by Kelledy Manson Breakdown of academic impact, for papers by Chantal Rabourdin‐Combe Breakdown of academic impact, for papers by Yves Rivière Breakdown of academic impact, for papers by Franziska Lechner Breakdown of academic impact, for papers by H. T. M. Cuypers Breakdown of academic impact, for papers by Ghalib Alkhatib
Rankless by CCL
2026